• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰西南部卵巢癌女性患者的外科治疗

The surgical management of women with ovarian cancer in the south west of England.

作者信息

Olaitan A, Weeks J, Mocroft A, Smith J, Howe K, Murdoch J

机构信息

Department of Gynaecological Oncology, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK.

出版信息

Br J Cancer. 2001 Dec 14;85(12):1824-30. doi: 10.1054/bjoc.2001.2196.

DOI:10.1054/bjoc.2001.2196
PMID:11747321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2364011/
Abstract

The surgical management of epithelial ovarian cancer in the South West of England was studied in the two years 1997-1998 in order to determine the factors that influence the outcome of surgery and to provide a baseline from which to assess the effect of centralisation of cancer services. All hospitals in the South West region of England participating in the Regional Cancer Organisation's longitudinal study of outcomes in gynaecological malignancies are included. Six hundred and eighty-two patients with epithelial ovarian cancer were registered with the RCO in the two-year study period. Five hundred and ninety-five women were offered primary cytoreductive surgery of which 438 were said to be optimally cytoreduced. Applying multivariate models to analyse the outcome of surgery, older patients (OR = 0.82 per 5-year increase in age, P = 0.0003), patients treated in hospitals managing fewer than ten cases of ovarian cancer per year (OR = 1.92, P = 0.02) and patients with FIGO stage 3 (OR = 0.02, P < 0.0001) or 4 (OR = 0.002, P < 0.0001) disease were less likely to be optimally cytoreduced. Gynaecological oncologists were 2.06 times more likely to attain optimal cytoreduction when compared to general gynaecologists and this was statistically significant (P = 0.01). The results from this study support the argument that limiting surgery for ovarian malignancy to specialised surgeons improves the extent of cytoreductive surgery.

摘要

为了确定影响手术结果的因素,并提供一个评估癌症服务集中化效果的基线,1997年至1998年的两年间,对英格兰西南部上皮性卵巢癌的手术治疗情况进行了研究。纳入了英格兰西南部地区所有参与区域癌症组织妇科恶性肿瘤纵向结局研究的医院。在为期两年的研究期间,有682例上皮性卵巢癌患者在区域癌症组织登记。595名女性接受了初次细胞减灭术,其中438例据说是达到了最佳细胞减灭效果。应用多变量模型分析手术结果,年龄较大的患者(年龄每增加5岁,比值比=0.82,P=0.0003)、在每年处理少于10例卵巢癌病例的医院接受治疗的患者(比值比=1.92,P=0.02)以及国际妇产科联盟(FIGO)分期为3期(比值比=0.02,P<0.0001)或4期(比值比=0.002,P<0.0001)疾病的患者达到最佳细胞减灭的可能性较小。与普通妇科医生相比,妇科肿瘤学家实现最佳细胞减灭的可能性高2.06倍,且具有统计学意义(P=0.01)。这项研究的结果支持了这样一种观点,即将卵巢恶性肿瘤手术限制于专科外科医生可提高细胞减灭术的程度。

相似文献

1
The surgical management of women with ovarian cancer in the south west of England.英格兰西南部卵巢癌女性患者的外科治疗
Br J Cancer. 2001 Dec 14;85(12):1824-30. doi: 10.1054/bjoc.2001.2196.
2
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.外科医生专业对卵巢癌患者护理过程及结局的影响。
J Natl Cancer Inst. 2006 Feb 1;98(3):172-80. doi: 10.1093/jnci/djj019.
3
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.由妇科肿瘤专科顾问医生进行手术可提高卵巢癌患者的生存率。
Cancer. 2006 Feb 1;106(3):589-98. doi: 10.1002/cncr.21616.
4
The management of women with apparent early ovarian cancer in the south-west region of England.英格兰西南部早期卵巢癌疑似患者的管理
J Obstet Gynaecol. 2002 Jul;22(4):394-8. doi: 10.1080/01443610220141353.
5
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.增加广泛的上腹部手术以实现最佳细胞减灭术可提高IIIC-IV期上皮性卵巢癌患者的生存率。
Gynecol Oncol. 2006 Dec;103(3):1083-90. doi: 10.1016/j.ygyno.2006.06.028. Epub 2006 Aug 4.
6
Surgery of advanced malignant epithelial tumours of the ovary.晚期卵巢恶性上皮性肿瘤的手术治疗
Forum (Genova). 2000 Oct-Dec;10(4):312-20.
7
Predictors of comprehensive surgical treatment in patients with ovarian cancer.卵巢癌患者综合手术治疗的预测因素。
Cancer. 2007 May 15;109(10):2031-42. doi: 10.1002/cncr.22604.
8
Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.荷兰卵巢癌患者的专科护理与生存情况:全国队列研究
J Natl Cancer Inst. 2008 Mar 19;100(6):399-406. doi: 10.1093/jnci/djn033. Epub 2008 Mar 11.
9
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.卵巢癌切除术后医院及外科医生手术量与患者预后的相关性
J Natl Cancer Inst. 2006 Feb 1;98(3):163-71. doi: 10.1093/jnci/djj018.
10
A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?一项基于人群的卵巢癌护理模式研究:哪些患者由妇科肿瘤学家诊治,哪些患者未得到诊治?
Gynecol Oncol. 2002 Jan;84(1):36-42. doi: 10.1006/gyno.2001.6460.

引用本文的文献

1
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.将卵巢癌肿瘤细胞减灭术的区域性分配给高容量中心,以及对纽约州患者出行的影响。
Gynecol Oncol. 2024 Mar;182:141-147. doi: 10.1016/j.ygyno.2024.01.004. Epub 2024 Jan 22.
2
The Relevance of Gynecologic Oncologists to Provide High-Quality of Care to Women with Gynecological Cancer.妇科肿瘤学家为妇科癌症患者提供高质量护理的相关性。
Front Oncol. 2016 Jan 14;5:308. doi: 10.3389/fonc.2015.00308. eCollection 2015.
3
Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders.在中国患有良性妇科疾病的女性中,血清人附睾蛋白4作为生物标志物比癌抗原125更合适。
Afr Health Sci. 2014 Dec;14(4):913-8. doi: 10.4314/ahs.v14i4.20.
4
Management of complex pelvic masses using a multivariate index assay: a decision analysis.采用多变量指标检测法处理复杂盆腔包块的管理:决策分析。
Gynecol Oncol. 2012 Sep;126(3):364-8. doi: 10.1016/j.ygyno.2012.05.027. Epub 2012 May 30.
5
Centralisation of services for gynaecological cancer.妇科癌症服务的集中化。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007945. doi: 10.1002/14651858.CD007945.pub2.
6
HE4 as a biomarker for ovarian and endometrial cancer management.人附睾蛋白4作为卵巢癌和子宫内膜癌管理的生物标志物。
Expert Rev Mol Diagn. 2009 Sep;9(6):555-66. doi: 10.1586/erm.09.39.
7
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.一种利用人附睾蛋白4(HE4)和癌抗原125(CA125)预测盆腔肿块患者卵巢癌的新型多标志物生物测定法。
Gynecol Oncol. 2009 Jan;112(1):40-6. doi: 10.1016/j.ygyno.2008.08.031. Epub 2008 Oct 12.
8
A case-control study to evaluate urinary tract complications in radical hysterectomy.一项评估根治性子宫切除术中泌尿系统并发症的病例对照研究。
World J Surg Oncol. 2005 Feb 16;3(1):12. doi: 10.1186/1477-7819-3-12.

本文引用的文献

1
The long learning curve of gynaecological cancer surgery: an argument for centralisation.
BJOG. 2000 Jan;107(1):19-23. doi: 10.1111/j.1471-0528.2000.tb11573.x.
2
Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.妇科专家与卵巢癌的生存结局:一项对1866名患者的苏格兰全国性研究。
Br J Obstet Gynaecol. 1999 Nov;106(11):1130-6. doi: 10.1111/j.1471-0528.1999.tb08137.x.
3
The management of cervical carcinoma within the south west region of England. Expert Tumour Panel.英格兰西南部地区宫颈癌的管理。专家肿瘤小组。
Br J Obstet Gynaecol. 1997 Feb;104(2):140-4. doi: 10.1111/j.1471-0528.1997.tb11033.x.
4
Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer.一项基于人群的上皮性卵巢癌研究中的治疗结果与预后因素
Gynecol Oncol. 1993 Jan;48(1):38-49. doi: 10.1006/gyno.1993.1007.
5
National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system.卵巢癌全国性调查。六、对当前国际妇产科联盟分期系统的批判性评估。
Cancer. 1993 Nov 15;72(10):3007-11. doi: 10.1002/1097-0142(19931115)72:10<3007::aid-cncr2820721024>3.0.co;2-n.
6
Management of ovarian cancer: referral to a multidisciplinary team matters.卵巢癌的管理:转诊至多学科团队很重要。
Br J Cancer. 1994 Aug;70(2):363-70. doi: 10.1038/bjc.1994.307.
7
The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.手术医生的专业领域对卵巢癌患者生存率的影响。
Br J Cancer. 1994 Nov;70(5):1014-7. doi: 10.1038/bjc.1994.440.
8
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).晚期上皮性卵巢癌的预后因素。(妇科肿瘤区域间合作组(GICOG))
Br J Cancer. 1990 Sep;62(3):444-50. doi: 10.1038/bjc.1990.315.
9
Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?晚期卵巢癌手术的Meta分析:最大程度肿瘤细胞减灭术是预后的独立决定因素吗?
Am J Obstet Gynecol. 1992 Feb;166(2):504-11. doi: 10.1016/0002-9378(92)91658-w.